Correct Answer: D. Seminoma
Seminoma is the most common testicular germ cell tumor (40–50% of all testicular cancers in India), arising from primordial germ cells. The histopathology hallmark is uniform sheets of large, pale, glycogen-rich cells with clear cytoplasm, prominent nucleoli, and a fibrous stroma containing lymphocytic infiltration. The tumor cells are arranged in nests separated by fibrous septa, often with a granulomatous reaction at the periphery. Immunohistochemistry shows positivity for PLAP (placental alkaline phosphatase) and OCT4, confirming germ cell origin. Seminomas are radiosensitive and chemosensitive, making them the most favorable prognosis among testicular germ cell tumors. In Indian clinical practice, seminoma typically presents in men aged 30–50 years with painless scrotal swelling, and orchidectomy is the standard treatment. The presence of uniform cytology without heterogeneous elements (yolk sac, teratoid, or embryonal differentiation) rules out non-seminomatous germ cell tumors (NSGCTs). Serum markers (AFP, β-hCG) are typically normal or only mildly elevated in pure seminoma, whereas NSGCTs show marked elevation.
Why the other options are wrong
A. Teratoma — Teratomas contain multiple germ layers (ectoderm, mesoderm, endoderm) with heterogeneous histology including cartilage, muscle, epithelium, and fat. The uniform pale cell population with clear cytoplasm seen here is pathognomonic for seminoma, not the mixed tissue architecture of teratoma. Teratomas are rare in adults and more common in children; they are also chemoresistant. B. Yolk-sac tumor — Yolk-sac tumors (endodermal sinus tumors) show microcystic/reticular patterns with Schiller-Duval bodies (papillary structures with central blood vessel). They produce elevated AFP and lack the uniform pale glycogen-rich cells with clear nuclei typical of seminoma. Yolk-sac tumors are more common in children and are part of NSGCTs in adults. C. Embryonal cell carcinoma — Embryonal carcinoma shows pleomorphic cells with high mitotic activity, glandular/papillary differentiation, and irregular nests. Unlike seminoma's uniform cytology, embryonal carcinoma has marked cellular atypia and heterogeneity. It produces elevated β-hCG and AFP and is part of NSGCTs with worse prognosis than seminoma. The orderly, homogeneous appearance rules this out.
High-Yield Facts
- Seminoma is the most common testicular germ cell tumor (40–50% incidence), with peak age 30–50 years in Indian males.
- Histologic hallmark: uniform sheets of pale, glycogen-rich cells with clear cytoplasm, prominent nucleoli, and lymphocytic stromal infiltration.
- PLAP and OCT4 positivity on immunohistochemistry confirm seminoma; serum markers (AFP, β-hCG) are normal or only mildly elevated.
- Seminomas are radiosensitive and chemosensitive with excellent prognosis (>95% 5-year survival for Stage I); NSGCTs have worse outcomes.
- Orchidectomy is the standard surgical treatment; adjuvant radiation or chemotherapy depends on stage (TNM classification).
- Pure seminoma does not contain heterogeneous elements (yolk sac, teratoid, embryonal); any NSGCT component downgrades prognosis and treatment.
Mnemonics
PALE SEMINOMA Pale glycogen-rich cells | Alkaline phosphatase (PLAP) positive | Lymphocytic stroma | Excellent prognosis. Use this to recall the classic pale appearance and favorable biology of seminoma versus the darker, more aggressive NSGCTs. GCT Marker Rule Seminoma → normal/mild markers | Yolk-sac → ↑↑ AFP | Embryonal → ↑ β-hCG, AFP | Choriocarcinoma → ↑↑↑ β-hCG. Helps differentiate germ cell tumors by serum marker pattern.
NBE Trap
NBE often pairs "scrotal swelling + orchidectomy" with non-seminomatous tumors (teratoma, yolk-sac) because students recall that NSGCTs are more common in children. However, in a 45-year-old with uniform pale histology and no marker elevation, seminoma is the correct answer—the age and histology are the discriminators.
Clinical Pearl
In Indian urology practice, a 45-year-old man with painless scrotal swelling and uniform pale histology on orchidectomy is seminoma until proven otherwise. The excellent response to adjuvant therapy (radiation or BEP chemotherapy per RNTCP guidelines) and >95% cure rate in early stages make early diagnosis and staging (CT chest/abdomen, tumor markers, LDH) critical for optimal outcomes.
_Reference: Bailey & Love Ch. 40 (Testicular Tumors); Robbins Ch. 21 (Germ Cell Tumors)_